192 related articles for article (PubMed ID: 31103628)
1. Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms.
Huang W; Sundquist J; Sundquist K; Ji J
Gastroenterology; 2019 Sep; 157(3):672-681.e4. PubMed ID: 31103628
[TBL] [Abstract][Full Text] [Related]
2. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Loeb S; Folkvaljon Y; Lambe M; Robinson D; Garmo H; Ingvar C; Stattin P
JAMA; 2015 Jun 23-30; 313(24):2449-55. PubMed ID: 26103029
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer.
Huang W; Sundquist J; Sundquist K; Ji J
Nat Commun; 2020 Jun; 11(1):3191. PubMed ID: 32581298
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.
Matthews A; Langan SM; Douglas IJ; Smeeth L; Bhaskaran K
PLoS Med; 2016 Jun; 13(6):e1002037. PubMed ID: 27299522
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer.
Lian Y; Yin H; Pollak MN; Carrier S; Platt RW; Suissa S; Azoulay L
Eur Urol; 2016 Nov; 70(5):808-815. PubMed ID: 27178449
[TBL] [Abstract][Full Text] [Related]
8. No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction.
Cea Soriano L; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):605-608. PubMed ID: 32267029
[TBL] [Abstract][Full Text] [Related]
9. Use of Melatonin Is Associated With Lower Risk of Colorectal Cancer in Older Adults.
Zhang N; Sundquist J; Sundquist K; Ji J
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00396. PubMed ID: 34342302
[TBL] [Abstract][Full Text] [Related]
10. Cholera Vaccine Use Is Associated With a Reduced Risk of Death in Patients With Colorectal Cancer: A Population-Based Study.
Ji J; Sundquist J; Sundquist K
Gastroenterology; 2018 Jan; 154(1):86-92.e1. PubMed ID: 28923497
[TBL] [Abstract][Full Text] [Related]
11. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study.
Ali Khan U; Fallah M; Sundquist K; Sundquist J; Brenner H; Kharazmi E
PLoS Med; 2020 Nov; 17(11):e1003431. PubMed ID: 33186354
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
14. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
Ji J; Sundquist J; Sundquist K
Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
de Kort S; Simons CC; van den Brandt PA; Goldbohm RA; Arts IC; de Bruine AP; Janssen-Heijnen ML; Sanduleanu S; Masclee AA; Weijenberg MP
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):896-903. PubMed ID: 27097356
[TBL] [Abstract][Full Text] [Related]
16. Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study.
Desautels D; Czaykowski P; Nugent Z; Demers AA; Mahmud SM; Singh H
Cancer; 2016 Apr; 122(8):1254-60. PubMed ID: 26919270
[TBL] [Abstract][Full Text] [Related]
17. Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
Oyeyemi SO; Braaten T; Licaj I; Lund E; Benjaminsen Borch K
BMC Cancer; 2018 Dec; 18(1):1216. PubMed ID: 30514263
[TBL] [Abstract][Full Text] [Related]
18. Combined Use of Aspirin and Selective Serotonin Reuptake Inhibitors Is Associated With Lower Risk of Colorectal Cancer: A Nested Case-Control Study.
Zhang N; Sundquist J; Sundquist K; Zhang ZG; Ji J
Am J Gastroenterol; 2021 Jun; 116(6):1313-1321. PubMed ID: 33661146
[TBL] [Abstract][Full Text] [Related]
19. Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia.
Cesta CE; Segovia Chacón S; Engeland A; Broe A; Damkier P; Furu K; Kieler H; Karlsson P
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2111-2118. PubMed ID: 34453753
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; de Lange T; Bagnardi V; Ursin G; Weiderpass E
BMJ Open; 2017 Nov; 7(11):e017639. PubMed ID: 29146641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
